Small tumor size; female sex; lack of cirrhosis; BCLC stage 0; high expression of APOL2, APOL3 and APOL6; and low AFP levels indicated higher survival rate in the GSE14520 cohort. This evidence concerns the gene APOL2 and neoplasm.